Hiro Shimada

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14

BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent of <i>CDKN2A</i> Repression

Dorothea Douglas, Jessie Hao-Ru Hsu, Long Hung et al. · Cancer Research · 2008 · 129 citations · Full text

Medicine, Genetics, Oncology +17

131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study

Gregory A. Yanik, Judith G. Villablanca, John M. Maris et al. · Biology of Blood and Marrow Transplantation · 2015 · 97 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

Image Analysis for Neuroblastoma Classification: Segmentation of Cell Nuclei

Metin N. Gürcan, Tony Pan, Hiro Shimada et al. · 2006 · 95 citations

Medicine, Oncology, Pathology +14

A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

Judith G. Villablanca, Samuel L. Volchenboum, Hwangeui Cho et al. · Pediatric Blood & Cancer · 2016 · 95 citations · Full text

Medicine, Oncology, Pharmacology +14